Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jinming Yu

Showing results (91-100 of 819) with videos related to

Pageof 82
Sort By:
Journal of Translational Medicine|October 10, 2021
XPO1-mutant NSCLC without STK11/KEAP1 mutations may predict better survival to immunotherapyXuanzong Li, Bing Zou, Shijiang Wang, et al.
Lung Cancer (Amsterdam, Netherlands)|November 10, 2019
Hyper-progressive disease in a patient with advanced non-small cell lung cancer on immune checkpoint inhibitor therapy: A case report and literature reviewDongxiao Zhang, Yan Zhang, Yong Huang, et al.
Cancer Management and Research|February 6, 2020
Radiotherapy for patients with completely resected pathologic IIIA(N2) non-small-cell lung cancer: a retrospective analysisYing Zhu, Lei Fu, Wang Jing, et al.
Journal of Cancer Research and Clinical Oncology|December 8, 2021
Correction to: Efficacy of single-site radiotherapy plus PD-1 inhibitors vs PD-1 inhibitors for oligometastatic non-small cell lung cancerPeiliang Wang, Tianwen Yin, Kaikai Zhao, et al.
Frontiers in Oncology|October 31, 2022
Postoperative radiotherapy might be a risk factor for second primary lung cancer: A population-based studyYou Mo, Minxin Chen, Meng Wu, et al.
Frontiers in Oncology|October 21, 2022
Development and feasibility evaluation of an AR-assisted radiotherapy positioning systemGongsen Zhang, Xinchao Liu, Linlin Wang, et al.
Oncoimmunology|April 22, 2020
Identifying optimal first-line interventions for advanced non-small cell lung carcinoma according to PD-L1 expression: a systematic review and network meta-analysisJie Liu, Chengming Li, Samuel Seery, et al.
Future Oncology (London, England)|May 30, 2018
Male patients with resected IIIA-N2 non-small-cell lung cancer may benefit from postoperative radiotherapy: a population-based survival analysisPeisi Kou, Haiyong Wang, Jiamao Lin, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|September 19, 2016
Postoperative radiation therapy of pT2-3N0M0 esophageal carcinoma-a reviewYijun Luo, Xiaoli Wang, Jinming Yu, et al.
Cancer Letters|September 15, 2014
PET/CT imaging-guided dose painting in radiation therapyXiaorong Shi, Xue Meng, Xindong Sun, et al.
Pageof 82

Showing results (91-100 of 819) with videos related to

Sort By:
Pageof 82
Journal of Translational Medicine|October 10, 2021
XPO1-mutant NSCLC without STK11/KEAP1 mutations may predict better survival to immunotherapyXuanzong Li, Bing Zou, Shijiang Wang, et al.
Lung Cancer (Amsterdam, Netherlands)|November 10, 2019
Hyper-progressive disease in a patient with advanced non-small cell lung cancer on immune checkpoint inhibitor therapy: A case report and literature reviewDongxiao Zhang, Yan Zhang, Yong Huang, et al.
Cancer Management and Research|February 6, 2020
Radiotherapy for patients with completely resected pathologic IIIA(N2) non-small-cell lung cancer: a retrospective analysisYing Zhu, Lei Fu, Wang Jing, et al.
Journal of Cancer Research and Clinical Oncology|December 8, 2021
Correction to: Efficacy of single-site radiotherapy plus PD-1 inhibitors vs PD-1 inhibitors for oligometastatic non-small cell lung cancerPeiliang Wang, Tianwen Yin, Kaikai Zhao, et al.
Frontiers in Oncology|October 31, 2022
Postoperative radiotherapy might be a risk factor for second primary lung cancer: A population-based studyYou Mo, Minxin Chen, Meng Wu, et al.
Frontiers in Oncology|October 21, 2022
Development and feasibility evaluation of an AR-assisted radiotherapy positioning systemGongsen Zhang, Xinchao Liu, Linlin Wang, et al.
Oncoimmunology|April 22, 2020
Identifying optimal first-line interventions for advanced non-small cell lung carcinoma according to PD-L1 expression: a systematic review and network meta-analysisJie Liu, Chengming Li, Samuel Seery, et al.
Future Oncology (London, England)|May 30, 2018
Male patients with resected IIIA-N2 non-small-cell lung cancer may benefit from postoperative radiotherapy: a population-based survival analysisPeisi Kou, Haiyong Wang, Jiamao Lin, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|September 19, 2016
Postoperative radiation therapy of pT2-3N0M0 esophageal carcinoma-a reviewYijun Luo, Xiaoli Wang, Jinming Yu, et al.
Cancer Letters|September 15, 2014
PET/CT imaging-guided dose painting in radiation therapyXiaorong Shi, Xue Meng, Xindong Sun, et al.
Pageof 82